Peter R. Studdy

903 total citations
12 papers, 656 citations indexed

About

Peter R. Studdy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Peter R. Studdy has authored 12 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Peter R. Studdy's work include Protein Hydrolysis and Bioactive Peptides (4 papers), Peptidase Inhibition and Analysis (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Peter R. Studdy is often cited by papers focused on Protein Hydrolysis and Bioactive Peptides (4 papers), Peptidase Inhibition and Analysis (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Peter R. Studdy collaborates with scholars based in United Kingdom and Australia. Peter R. Studdy's co-authors include R.G. Bird, David G. James, Ruth Lapworth, Sheila Sherlock, I I Coutts, A Dewar, W D Riding, A J Newman-Taylor, B Corrin and Aidan Davison and has published in prestigious journals such as The Lancet, Thorax and Journal of Clinical Pathology.

In The Last Decade

Peter R. Studdy

12 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Studdy United Kingdom 10 285 242 149 114 72 12 656
Kaoru Hamada Japan 18 317 1.1× 312 1.3× 209 1.4× 43 0.4× 116 1.6× 36 952
Adrian Kruit Netherlands 13 269 0.9× 189 0.8× 143 1.0× 58 0.5× 40 0.6× 17 549
Hideaki Yamasawa Japan 15 356 1.2× 188 0.8× 96 0.6× 32 0.3× 51 0.7× 52 632
E. Amundsen Norway 17 129 0.5× 48 0.2× 116 0.8× 32 0.3× 71 1.0× 67 764
Fumio Yanai Japan 16 171 0.6× 66 0.3× 71 0.5× 204 1.8× 268 3.7× 33 898
Tokuji Matsuba Japan 10 448 1.6× 93 0.4× 232 1.6× 27 0.2× 62 0.9× 17 749
Shigeru Kohno Japan 11 83 0.3× 141 0.6× 230 1.5× 23 0.2× 200 2.8× 13 592
Emiko Ono Japan 17 405 1.4× 533 2.2× 87 0.6× 30 0.3× 27 0.4× 47 993
Zhe Zhou China 13 488 1.7× 104 0.4× 207 1.4× 29 0.3× 28 0.4× 44 805
William T. Newton United States 13 122 0.4× 53 0.2× 112 0.8× 42 0.4× 40 0.6× 40 678

Countries citing papers authored by Peter R. Studdy

Since Specialization
Citations

This map shows the geographic impact of Peter R. Studdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Studdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Studdy more than expected).

Fields of papers citing papers by Peter R. Studdy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Studdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Studdy. The network helps show where Peter R. Studdy may publish in the future.

Co-authorship network of co-authors of Peter R. Studdy

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Studdy. A scholar is included among the top collaborators of Peter R. Studdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Studdy. Peter R. Studdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Studdy, Peter R. & R.G. Bird. (1989). Serum Angiotensin Converting Enzyme in Sarcoidosis—Its Value in Present Clinical Practice. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 26(1). 13–18. 89 indexed citations
2.
Studdy, Peter R., et al.. (1984). Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowing. British Journal of Diseases of the Chest. 78(1). 46–54. 17 indexed citations
3.
Rudd, Robin, et al.. (1983). Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M & B 22,948). British Journal of Diseases of the Chest. 77(1). 78–86. 34 indexed citations
4.
Studdy, Peter R., Ruth Lapworth, & R.G. Bird. (1983). Angiotensin-converting enzyme and its clinical significance--a review.. Journal of Clinical Pathology. 36(8). 938–947. 125 indexed citations
6.
Law, Michael, et al.. (1982). Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma. British Journal of Diseases of the Chest. 76(2). 151–156. 3 indexed citations
7.
Studdy, Peter R., et al.. (1982). Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type.. Thorax. 37(6). 462–465. 36 indexed citations
8.
Short, Michael D., et al.. (1981). The labelling and monitoring of lung deposition of an inhaled synthetic anticholinergic bronchodilating agent.. PubMed. 80(6 Suppl). 918–21. 22 indexed citations
9.
Studdy, Peter R., R.G. Bird, E Neville, & David G. James. (1980). Biochemical findings in sarcoidosis.. Journal of Clinical Pathology. 33(6). 528–533. 51 indexed citations
10.
Studdy, Peter R., R.G. Bird, & David G. James. (1979). Serum Angiotensin Converting Enzyme in Sarcoidosis and other Granulomatous Disorders. Clinical Science. 56(3). 31P–31P. 8 indexed citations
11.
Studdy, Peter R., R.G. Bird, David G. James, & Sheila Sherlock. (1978). SERUM ANGIOTENSIN-CONVERTING ENZYME (SACE) IN SARCOIDOSIS AND OTHER GRANULOMATOUS DISORDERS. The Lancet. 312(8104). 1331–1334. 132 indexed citations
12.
Studdy, Peter R. & J M T Willoughby. (1976). Non-bacterial thrombotic endocarditis in early cancer.. BMJ. 1(6012). 752–752. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026